Physician profile
Jay H Alexander
NPI 1417977539
$744,430.65
in general payments reported to CMS, 2019-2025
18 companies · $17.25 in 2025
The $17.25 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111K · 2020: $126K · 2021: $127K · 2022: $127K · 2023: $127K · 2024: $126K · 2025: $17.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $252K · Travel and Lodging: $1,153 · Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $252,000.00 |
| Travel and Lodging | $1,153.16 |
| Food and Beverage | $313.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $739,839.35 | 2019-2024 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $1,151.19 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $791.68 | 2019-2022 | |
| Novo Nordisk INC | $547.00 | 2019-2023 | |
| Amgen INC. | $367.64 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $208.59 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $207.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.34 | 2019-2021 | |
| Edwards Lifesciences Corporation | $161.65 | 2022 | |
| Amarin Pharma, INC. | $156.74 | 2019-2021 | |
| Pfizer INC. | $151.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.24 | 2019-2021 | |
| Medtronic, INC. | $117.00 | 2021 | |
| Medtronic Vascular, INC. | $111.02 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.28 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $94.64 | 2021 | |
| Boston Scientific Corporation | $78.26 | 2019-2020 | |
| Teleflex LLC | $17.25 | 2025 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.